Haleon plc - stock earnings
HLN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -3.8 million USD | 3.5 billion USD |
| 2023Q3 | 445.2 million USD | 3.4 billion USD |
| 2023Q2 | 376.2 million USD | 3.5 billion USD |
| 2023Q1 | 482.0 million USD | 3.7 billion USD |
| 2022Q4 | 239.6 million USD | 4.6 billion USD |
| 2022Q3 | 383.6 million USD | 3.2 billion USD |
| 2022Q2 | 244.2 million USD | 3.1 billion USD |
| 2022Q1 | 449.6 million USD | 3.4 billion USD |
| 2021Q4 | 714.1 million USD | 2.0 billion USD |
| 2021Q3 | 500.1 million USD | 3.4 billion USD |
| 2021Q1 | 321.1 million USD | 3.2 billion USD |
HLN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.3 billion USD | 14.4 billion USD |
| 2022 | 1.3 billion USD | 13.1 billion USD |
| 2021 | 1.9 billion USD | 12.9 billion USD |
| 2020 | 1.6 billion USD | 13.5 billion USD |
| 2019 | 858.9 million USD | 11.1 billion USD |
HLN
Price: $8.46
52 week price:
Dividend Yield: 0.01%
5-year range yield:
Forward Dividend Yield: 2.52%
Payout Ratio: 62.56%
Payout Ratio Range:
Dividend Per Share: 0.21 USD
Earnings Per Share: 0.29 USD
P/E Ratio: 24.65
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 23.3 million
Market Capitalization: 37.9 billion
Years Paying Dividends: 2